Literature DB >> 5359191

Recognition and treatment of chronic liver disease in the disadvantaged.

C M Leevy.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 5359191      PMCID: PMC2611792     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  20 in total

1.  MESENCHYMAL-CELL PROLIFERATION IN LIVER DISEASE OF THE ALCOHOLIC.

Authors:  C M LEEVY; W TENHOVE; M HOWARD
Journal:  JAMA       Date:  1964-02-22       Impact factor: 56.272

2.  B-COMPLEX VITAMINS IN LIVER DISEASE OF THE ALCOHOLIC.

Authors:  C M Leevy; H Baker; W Tenhove; O Frank; G R Cherrick
Journal:  Am J Clin Nutr       Date:  1965-04       Impact factor: 7.045

Review 3.  CLINICAL ASPECTS OF THE HEPATIC CIRCULATION.

Authors:  C M LEEVY
Journal:  Gastroenterology       Date:  1965-06       Impact factor: 22.682

4.  A plasma card test for rapid serodiagnosis of schistosomiasis (SPC).

Authors:  E H SADUN; R I ANDERSON; M J SCHOENBECHLER
Journal:  Proc Soc Exp Biol Med       Date:  1963-02

5.  Clinical estimation of liver size.

Authors:  J NAFTALIS; C M LEEVY
Journal:  Am J Dig Dis       Date:  1963-03

6.  Histopathologic study of acute nonfatal hepatitis.

Authors:  T C KELLER; B GIGES; H F SMETANA
Journal:  Mil Surg       Date:  1951-10

7.  Observations on hepatic oxygen metabolism in man.

Authors:  C M LEEVY; W GEORGE; W LESKO; M DEYSINE; C C ABBOTT; E J HALLIGAN
Journal:  JAMA       Date:  1961-11-11       Impact factor: 56.272

8.  Virus-like particles in sera of patients with infectious and serum hepatitis.

Authors:  R J Hirschman; N R Shulman; L F Barker; K O Smith
Journal:  JAMA       Date:  1969-06-02       Impact factor: 56.272

9.  Cirrhosis in alcoholics.

Authors:  C M Leevy
Journal:  Med Clin North Am       Date:  1968-11       Impact factor: 5.456

View more
  1 in total

Review 1.  Hepatitis in the individual.

Authors:  C M Leevy; C H Tamburro; M F Sorrell; R Stone
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.